Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages 350-354

  Ames, Paul R J ^a   Batuca, Joana R ^b   Muncy, Ivana J ^c   De La Torre, Ignacio Garcia ^d   Pascoe Gonzales, Sara ^e   Guyer, K ^f   Matsuura, E ^g   Lopez, Luis R ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NOVA MEDICAL SCHOOL   (Portugal)

^c Division of Medicine   (United States)

^d HOSPITAL GENERAL DE OCCIDENTE   (Mexico)

^e UNIVERSITY OF GUADALAJARA   (Mexico)

^f INDIANA UNIVERSITY SOUTH BEND   (United States)

^g OKAYAMA UNIVERSITY   (Japan)

Author keywords

Aspirin resistance; Diabetes; Oxidative stress; Platelet inhibition; Thromboxane

Indexed keywords

11 OXOTHROMBOXANE B2; 8 ISOPROSTAGLANDIN F2 ALPHA; ACETYLSALICYLIC ACID; ARYLDIALKYLPHOSPHATASE 1; CREATININE; NITRATE; NITRITE; PADGEM PROTEIN; THROMBOXANE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; TREATMENT RESPONSE; URINARY EXCRETION;

ADMINISTRATION, ORAL; ANTIOXIDANTS; ASPIRIN; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; THROMBOXANE B2;

EID: 84865260242     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.03.025     Document Type: Article

References (26)

1. C. Patrono, L.A. Garcia-Rodriguez, R. Landolfi, and C. Baigent Low-dose aspirin for the prevention of atherothrombosis N Engl J Med 353 2005 2373 2383
2. A.O. Maree, and D.J. Fitzgerald Variable platelet response to aspirin and clopidogrel in atherothrombotic disease Circulation 115 2007 2196 2207
3. I.A. Reilly, and G.A. FitzGerald Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with antiplatelet inhibitory drugs Blood 69 1987 180 186
4. G.J. Hankle, and J.W. Eikelboom Aspirin resistance Lancet 367 2006 606 617
5. N. Zimmermann, and T. Hohlfeld Clinical implications of aspirin resistance Thromb Haemost 100 2008 379 390
6. M. Friend, I. Vucenik, and M. Miller Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidemia BMJ 326 2003 82 83
7. J.W. Eikelboom, J. Hirsh, J.I. Weitz, M. Johnston, Q. Yi, and S. Yusuf Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events Circulation 105 2002 1650 1655
8. J.W. Eikelboom, G.J. Hankey, J. Thom, D.L. Bhatt, G. Steg, and G. Montalescot Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid. Determinants and effects on cardiovascular risk Circulation 118 2008 1705 1712
9. S. Butalia, A.A. Leung, W.A. Ghali, and D.M. Rabi Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis Cardiovasc Diabetol 10 2011 25
10. N.J. Breet, J.W. Van Werkum, H.J. Bouman, J.C. Kelder, J.M. Ten Berg, and C.M. Hackeng High on-aspirin platelet reactivity as measured with aggregation-based cycloxygenase-1 inhibition sensitive platelet function tests is associated with the occurrence of atherthombotic events J Thromb Haemost 8 2010 2140 2148
11. S. Rajagopalan, I. Ford, P. Bachoo, G.S. Hillis, B. Croal, and M. Greaves Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery J Thromb Haemost 5 2007 2028 2035
12. I. Russo, C. Frascaroli, L. Mattiello, M. Viretto, C. Barale, and G. Doronzo Aspirin resistance subjects present a pro-inflammatory milieu with an increased oxidative stress: in these conditions, high glucose fails to influence platelet response to agoinists Diabetologia 54 Suppl. 1 2011 S36
13. I. Russo, M. Traversa, K. Bonomo, A. DeSalve, L. Mattiello, and P. DelMese In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin Obesity 18 2010 788 797
14. L.H. Gonçalves, L.M. Dusse, A.P. Fernandes, K.B. Gomes, M.O. Sóter, and M.T. Alves Urinary 11-dehydro thromboxane B levels in type 2 diabetic patients before and during aspirin intake Clin Chim Acta 412 2011 1366 1370
15. N.K. Gopaul, E.E. Anggård, A.I. Mallet, D.J. Betteridge, S.P. Wolff, and J. Nourooz-Zadeh Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus FEBS Lett 368 1995 225 229
16. S. O'Byrne, P. Forte, L.J. Roberts II, J.D. Morrow, A. Johnston, and E. Anggård Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion Diabetes 49 2000 857 862
17. A.T. Nurden Platelets, inflammation and tissue regeneration Thromb Haemost 105 Suppl. 1 2011 S13 S33
18. K.J. Woollard, and J. Chin-Dusting P-selectin antagonism in inflammatory disease Curr Pharm Des 16 2010 4113 4118
19. H. El-Mesallamy, N. Hamdy, S. Suwailem, and S. Mostafa Oxidative stress and platelet activation: markers of myocardial infarction in type 2 diabetes mellitus Angiology 61 2010 14 18
20. G.A. FitzGerald, J.A. Oates, J. Hawiger, R.L. Maas, L.J. Roberts II, and J.A. Lawson Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man J Clin Invest 71 1983 678 688
21. F. Santilli, B. Rocca, R. De Cristofaro, S. Lattanzio, L. Pietrangelo, and A. Habib Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance" J Am Coll Cardiol 53 2009 667 677
22. J. DiChiara, K.P. Bliden, U.S. Tantry, M.S. Hamed, M.J. Antonino, and T.A. Suarez The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study Diabetes 56 2007 3014 3019
23. A. Csiszar, G. Stef, P. Pacher, and Z. Ungvari Oxidative stress-induced isoprostane formation may contribute to aspirin resistance in platelets Prostaglandins Leukot Essent Fatty Acids 66 2002 557 558
24. E. Schwedhelm, A. Bierend, R. Maas, R. Trinks, G.D. Kom, and D. Tsikas Redox-generated isoprostanes are associated with residual platelet activity in aspirin-treated patients with stable coronary heart disease J Thromb Haemost 8 2010 2662 2670
25. H.J. Ting, and F.T. Khasawneh Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family? J Biomed Sci 17 2010 24
26. P. Pignatelli, R. Carnevale, S. Di Santo, S. Bartimoccia, V. Sanguigni, and L. Lenti Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction Arterioscler Thromb Vasc Biol 31 2011 423 434